<VariationArchive VariationID="56722" VariationName="NM_018965.4(TREM2):c.313del (p.Ala105fs)" VariationType="Deletion" Accession="VCV000056722" Version="17" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2013-07-24" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="71361" VariationID="56722">
      <GeneList>
        <Gene Symbol="TREM2" FullName="triggering receptor expressed on myeloid cells 2" GeneID="54209" HGNC_ID="HGNC:17761" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="41158508" stop="41163116" display_start="41158508" display_stop="41163116" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="41126245" stop="41130921" display_start="41126245" display_stop="41130921" Strand="-" />
          </Location>
          <OMIM>605086</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018965.4(TREM2):c.313del (p.Ala105fs)</Name>
      <CanonicalSPDI>NC_000006.12:41161340:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="41161341" stop="41161341" display_start="41161341" display_stop="41161341" variantLength="1" positionVCF="41161340" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="41129079" stop="41129079" display_start="41129079" display_stop="41129079" variantLength="1" positionVCF="41129078" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A105fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.41129079del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.41129079del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.41161341del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.41161341del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011561.1" sequenceAccession="NG_011561" sequenceVersion="1" change="g.6844del">
            <Expression>NG_011561.1:g.6844del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271821.2" sequenceAccession="NM_001271821" sequenceVersion="2" change="c.313del">
            <Expression>NM_001271821.2:c.313del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258750.1" sequenceAccession="NP_001258750" sequenceVersion="1" change="p.Ala105fs">
            <Expression>NP_001258750.1:p.Ala105fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018965.4" sequenceAccession="NM_018965" sequenceVersion="4" change="c.313del" MANESelect="true">
            <Expression>NM_018965.4:c.313del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061838.1" sequenceAccession="NP_061838" sequenceVersion="1" change="p.Ala105fs">
            <Expression>NP_061838.1:p.Ala105fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_631" sequenceAccession="LRG_631">
            <Expression>LRG_631:g.6844del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA264196" DB="ClinGen" />
        <XRef Type="rs" ID="386834141" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018965.4(TREM2):c.313del (p.Ala105fs) AND Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1" Accession="RCV000050135" Version="2">
        <ClassifiedConditionList TraitSetID="1445">
          <ClassifiedCondition DB="MedGen" ID="C4721893">Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018965.4(TREM2):c.313del (p.Ala105fs) AND not provided" Accession="RCV002054878" Version="15">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-07-24" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15883308</ID>
        </Citation>
        <DescriptionHistory Dated="2022-04-07">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1445" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3988" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1</ElementValue>
                <XRef ID="MONDO:0020749" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PLOSL1</ElementValue>
                <XRef Type="MIM" ID="221770" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) is characterized by fractures (resulting from radiologically demonstrable polycystic osseous lesions), frontal lobe syndrome, and progressive presenile dementia beginning in the fourth decade. The clinical course of PLOSL can be divided into four stages: 1. The latent stage is characterized by normal early development. 2. The osseous stage (3rd decade of life) is characterized by pain and tenderness, mostly in ankles and feet, usually following strain or injury. Fractures are typically diagnosed several years later, most commonly in the bones of the extremities. 3. In the early neurologic stage (4th decade of life), a change of personality begins to develop insidiously. Affected individuals show a frontal lobe syndrome (loss of judgment, euphoria, loss of social inhibitions, disturbance of concentration, and lack of insight, libido, and motor persistence) leading to serious social problems. 4. The late neurologic stage is characterized by progressive dementia and loss of mobility. Death usually occurs before age 50 years.</Attribute>
                <XRef ID="NBK1197" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301376</ID>
                <ID Source="BookShelf">NBK1197</ID>
              </Citation>
              <XRef ID="2770" DB="Orphanet" />
              <XRef ID="C4721893" DB="MedGen" />
              <XRef ID="MONDO:0020749" DB="MONDO" />
              <XRef Type="MIM" ID="221770" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="131934" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS270" />
        <ClinVarAccession Accession="SCV000082545" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">15883308</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018965.2:c.313delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="221770" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4720208" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-04-08">
        <ClinVarSubmissionID localKey="113039|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002497406" DateUpdated="2024-07-15" DateCreated="2022-04-08" Type="SCV" Version="15" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>TREM2: PVS1, PM2, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TREM2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="G" referenceAllele="GC" start="41129078" stop="41129079" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4720208" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="131934" TraitType="Disease" MappingType="Name" MappingValue="Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy" MappingRef="Preferred">
        <MedGen CUI="C1857316" Name="Polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

